Pharmacology

Download as ppt, pdf, or txt
Download as ppt, pdf, or txt
You are on page 1of 18

Drug Forms

Jim Cimino
A Modest Goal
• Mapping actual drugs to Clinical Drug terms
• Exchanging Clinical Drug terms sufficient for a
variety of purposes
• Question:
– Will some loss of information be acceptable?
– Does decision support care about pill vs. capsule?
Clincial Drug Review
• Active ingredients
– Chemical
– Form Strength
• Strength amount
• Strength units
• Volume
• Volume units
• Dosage form
Focus on Dosage Form

• 3982 comparisons
• 111 synonyms
• 72% match rate
• What went wrong?
Examination of Dosage Forms
• Compare use of each form, in each
source, with use in other sources for
corresponding medications
• Look for irregularities in source
• Look for 100% agreement
• When not 100% agreement, look at
hierarchical subsumption
Irregularities in Sources
NDC: 0000153144|FLUORITAB TABLETS CHEWABLE CHERRY|1.1|MG|
TAB CHEW|100|BOT:
A:: |FLUORITAB 0.5MG TABLET CHEW^SODIUM FLUORIDE|
CHEWABLE TABLET|SODIUM FLUORIDE^00000000.500^MG
^0000.000^

B: |FLUORITAB CHERRY TABS CHEW, 0.5MG|CHEWABLE TABLET|


SODIUM FLUORIDE^1.100000^MG^^

C: |SODIUM FLUORIDE CHEW TAB 1.1 MG (0.5MG F)|CHEWABLE


TABLET|SODIUM FLUORIDE^1.1000^MG^^
D: ||TABLET|SODIUM FLUORIDE^0.5^MG^^
Near Misses and the Hierarchy
Tablet
is-a Sodium Fluoride
1.1 MG D
Chewable Tablet
Tablet
is-a

A
Sodium Fluoride
1.1 MG
B Chewable Tablet
C
Irregularities in Sources
NDC: 0000014889|PROPRANOLOL HYDROCHLORIDE EXTENDED
RELEASE CAPSULES|80|MG|CAP ER|100|BOT

A: ||CAPSULE CR|PROPRANOLOL HYDROCHLORIDE^80^MG^^


B: |PROPRANOLOL 80MG CAPSULE SA^PROPRANOLOL HCL|
CAPSULE CR|PROPRANOLOL HCL^00000080.000^MG^0000.000^
C:: |PROPRANOLOL HCL CAP CR 80 MG|CAPSULE CR|
PROPRANOLOL HYDROCHLORIDE^80.0000^MG^^

D:: |PROPRANOLOL HYDROCHLORIDE^80 MG|CAPSULE CR|


PROPRANOLOL HYDROCHLORIDE^80^MILLIGRAM(S)^1^EACH

E:: |PROPRANOLOL HCL TABS CR, 80MG|TABLET CR|PROPRANOLOL


HYDROCHLORIDE^80.000000^MG^^
Example of 100% Agreement

A: LOTION: 1: LOTION|
B: LOTION: 1: LOTION|
C: LOTION: 1: LOTION|
D: LOTION: 1: LOTION|
E: LOTION: 1: LOTION|
Example of 100% Agreement
A: TABLET CR: 14: TAB E REL|TAB FC ER
B: TABLET CR: 6: TAB FC ER|TAB SUG CO|
C: TABLET CR: 9: TAB FC ER|TAB E REL|
D: TABLET CR: 14: TAB E REL|TAB FC ER|TAB FC|
E: TABLET CR: 7: TAB FC ER|TAB E REL|
Example of <100% Agreement
A: AEROSOL: 2: INHALANT|AEROSL SPR|
B: AEROSOL: 1: INHALANT|
C: AEROSOL: 1: INHALANT|
SPRAY, TOPICAL, DERMAL: 1: AEROSL SPR|
D: AEROSOL: 2: INHALANT|AEROSL SPR|
E: AEROSOL: 1: INHALANT|
Handling Ambiguity
Aerosol
Terbutaline Triamcinolone
Sulfate is-a Acetonide
A 0.2mg/ACT A
Inhaled Dermal 0.147mg/GM
Aerosol Aerosol
D Aerosol Aerosol
is-a is-a
B
Terbutaline Triamcinolone
C Sulfate Acetonide
0.2mg/ACT 0.147mg/GM C
E
Inhaled Aerosol Dermal Aerosol
Example of Subsumption
Aerosol ():
A(AEROSOL) D(AEROSOL)

Inhaled Aerosol (INHALENT):


B(AEROSOL) C(AEROSOL) E(AEROSOL)

Dermal Aerosol (AEROSL SPR):


C(SPRAY TOPICAL, DERMAL)
No Solution for Solution
AMPUL ELIXIR DROPS, OPHTHALMIC
DROPS INJ REPOSITORY (NON-SYSTEMIC)
INFUS. BTL INJECTION INJECTION
INJECTION INJECTION TYPE IRRIGATION
IRRIGATION INJECTION IVPB SOLUTION
SOLUTION KIT KIT, INJECTION
IV SOLN. LIQUID (SYSTEMIC)
KIT SOLUTION SOLUTION FOR
PIGGYBACK SUSPENSION DROPS, OTIC
PLAST. BAG SOLUTION FOR
SKIN TEST INHALATION...
SOLUTION CONCENTRATE SOLUTION
SYRUP INJECTION OPHTMALMIC…
VIAL KIT SOLUTION, ORAL
NEBU (SYSTEMIC)
OIL SOLUTION, OTIC
SOLUTION SOLUTION, TOPICAL,
SYRUP DERMAL
SYRUP
Hierarchy Thus Far
Capsule (CAPSULE, CAP GEL CO) Aerosol ()
Capsule EC (CAP DR PEL) Inhaled Aerosol (INHALENT)
Capsule CR (CAP ER) Dermal Aerosol (AEROSL SPR)
Capsule CR 12 HR (CAP ER) Cream (CREAM)
Capsule CR 24 HR (CAP ER) Lotion (LOTION)
Tablet (TABLET) Shampoo (SHAMPOO)
Chewable Tablet (TAB CHEW) Ointment (OINTMENT)
Sublingual Tablet (TABLET) Dressing (OINTMENT)
Tablet Ultra MCR (TABLET) Patch ():
Tablet CR (TAB FC, TAB FC ER, 24 Hour Patch TD24 (FILM ER)
TAB E REL, TAB SUG CO) Biweekly Patch (PATCH ER)
Tablet CR 12HR (TAB FC ER, Rectal Suppository (SUPP)
TAB E REL) Topical Dermal Powder (POWDER)
Tablet CR 24HR (TAB FC, TAB E REL,
TAB SUG CO)
Coated Tablet (TAB COAT)
Enteric Coated Tablet (TAB D REL)
Tablet SA OSM (TAB E REL)
Liquid/Solution Hierarchy
Oral (Systemic) Liquid/Solution Concentrate
Oral Concentrate Oral Concentrate
Oral Suspension Irrigation Solution
Powder for Oral (Systemic) Suspension Drops
Controlled Release Suspension Drops Suspension
Syrup Suspension for Ophthalmic Drops
Elixir Ophthalmic Drops
Injection Solution for Otic Drops
Ampule Dermal Topical Liquid/Solution
Infusion Bottle Gel
Repository Injection Oil
Intravenous Solution Powder for Reconstitution
IV Piggyback Solution for Oral Inhalation
Intraperitoneal Solution Nebulizer
Injection Kit Solution for Oral Mucous Membranes
Plastic Bag Ophthalmic Solution
Powder for Injection Ophthalmic Drops
Skin Test Suspension for Ophthalmic Drops
Suspension Otic Solution
Oral Suspension Solution for Otic Drops
Powder for Oral (Systemic) Suspension Vial
Controlled Release Suspension
12 Hour Controlled Release Suspension
Drops Suspension
Suspension for Ophthalmic Drops
Suspension for Reconstitution
Other Hierarchy
Kit
Injection Kit
Miscellaneous Routes Kit
Powder
Powder for Injection
Powder for Reconstitution
Powder for Oral (Systemic) Suspension
Where Do We Go From Here?
• Work thus far is based on previous sample
• Can a complete hierarchy be developed?
• Will changes in editorial policy be needed?
• If it should be done, who will do it?

You might also like